Join
Live feed
·
INSIDERFilingvia Quantisnow
Dermata Therapeutics Inc. logo

Director Scott Kathleen D. sold $13 worth of shares (11 units at $1.19), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DRMA· Dermata Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRMA (Dermata Therapeutics Inc.) and more on Quantisnow.